BlackRock Investment Management’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$526K Buy
27,715
+204
+0.7% +$3.91K ﹤0.01% 3032
2016
Q3
$610K Buy
27,511
+30
+0.1% +$563 ﹤0.01% 2943
2016
Q2
$502K Buy
27,481
+7,230
+36% +$124K ﹤0.01% 3068
2016
Q1
$368K Buy
20,251
+349
+2% +$5.65K ﹤0.01% 3012
2015
Q4
$336K Buy
19,902
+70
+0.4% +$1.19K ﹤0.01% 3136
2015
Q3
$357K Sell
19,832
-615
-3% -$13.7K ﹤0.01% 3133
2015
Q2
$529K Buy
20,447
+4,139
+25% +$105K ﹤0.01% 3102
2015
Q1
$357K Buy
+16,308
New +$352K ﹤0.01% 3087

Other funds holding ENTL

BlackRock Investment Management's ENTL Position: Q4 2016 in Review

BlackRock Investment Management increased its Entellus Medical, Inc. Common Stock (ENTL) stake by 0.74% in Q4 2016, buying an estimated $3.91K and bringing the position to 27,715 shares worth $526K. The position accounts for ﹤0.01% of the portfolio, ranked #3032.

BlackRock Investment Management first reported a position in ENTL in Q1 2015 and has held it in 8 quarters since. The position peaked at $610K in Q3 2016. 63 funds tracked by Wall St. Rank hold ENTL as of Q4 2016.

  • BlackRock Investment Management held 27,715 shares of Entellus Medical, Inc. Common Stock worth $526K as of Q4 2016.
  • BlackRock Investment Management bought 204 Entellus Medical, Inc. Common Stock shares in Q4 2016, an estimated $3.91K.
  • Entellus Medical, Inc. Common Stock made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3032 holding.
  • BlackRock Investment Management first reported a position in Entellus Medical, Inc. Common Stock in Q1 2015 and has held it in 8 quarters since.
  • BlackRock Investment Management's Entellus Medical, Inc. Common Stock position peaked at $610K in Q3 2016.
  • 63 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.